ATE509620T1 - Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz - Google Patents

Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz

Info

Publication number
ATE509620T1
ATE509620T1 AT07730181T AT07730181T ATE509620T1 AT E509620 T1 ATE509620 T1 AT E509620T1 AT 07730181 T AT07730181 T AT 07730181T AT 07730181 T AT07730181 T AT 07730181T AT E509620 T1 ATE509620 T1 AT E509620T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
active substance
poorly water
oral pharmaceutical
soluble active
Prior art date
Application number
AT07730181T
Other languages
English (en)
Inventor
Henricus R M Gorissen
Original Assignee
Abbott Healthcare Products Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv
Application granted granted Critical
Publication of ATE509620T1 publication Critical patent/ATE509620T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT07730181T 2006-06-16 2007-06-15 Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz ATE509620T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81407606P 2006-06-16 2006-06-16
EP06115582 2006-06-16
PCT/EP2007/055937 WO2007144418A1 (en) 2006-06-16 2007-06-15 Oral pharmaceutical composition of a poorly water-soluble active substance

Publications (1)

Publication Number Publication Date
ATE509620T1 true ATE509620T1 (de) 2011-06-15

Family

ID=38475902

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07730181T ATE509620T1 (de) 2006-06-16 2007-06-15 Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz

Country Status (10)

Country Link
EP (1) EP2034967B1 (de)
JP (1) JP2009539940A (de)
KR (1) KR20090032085A (de)
AT (1) ATE509620T1 (de)
AU (1) AU2007259252A1 (de)
CA (1) CA2654111A1 (de)
EA (1) EA014898B1 (de)
IL (1) IL195531A0 (de)
NO (1) NO20090163L (de)
WO (1) WO2007144418A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2753129T3 (es) * 2011-12-09 2020-04-07 Merck Patent Gmbh Carbonato de sodio libre de agua, con bajo contenido en poros

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
TW200633713A (en) * 2004-12-23 2006-10-01 Solvay Pharm Bv Oral immediate release formulation of a poorly water-soluble active substance
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders

Also Published As

Publication number Publication date
AU2007259252A1 (en) 2007-12-21
EA200970020A1 (ru) 2009-06-30
IL195531A0 (en) 2009-09-01
EA014898B1 (ru) 2011-02-28
WO2007144418A1 (en) 2007-12-21
JP2009539940A (ja) 2009-11-19
NO20090163L (no) 2009-01-14
EP2034967A1 (de) 2009-03-18
KR20090032085A (ko) 2009-03-31
CA2654111A1 (en) 2007-12-21
EP2034967B1 (de) 2011-05-18

Similar Documents

Publication Publication Date Title
CL2007003491A1 (es) Forma cristalina del acido (3s)-3-[n-(n-(2-tercbutilfenil)oxamil)alaninil]amino-5(23,5,6-tetrafluorofenoxi)-4-oxopentanoico; composicion farmaceutica que comprende a dicho compuesto; y su uso para tratar la fibrosis hepatica.
AU2003261167A1 (en) Liquid dosage compositions of stable nanoparticulate active agents
CR9626A (es) Formas de dosificacion de liberacion retardada oral altamente biodisponible de un o-desmetilvenlafaxin succinato
ES2721148T3 (es) Composiciones farmacéuticas de paclitaxel, análogos de paclitaxel o conjugados de paclitaxel y métodos relacionados de preparación y uso
BRPI0518781A2 (pt) formulaÇço farmacÊutica, processo para preparar uma formulaÇço farmacÊutica, e, uso de um composto
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
WO2007022023A3 (en) Film forming spreading agents
AR061134A1 (es) Derivados de tioxantina
ATE522204T1 (de) Beschichtete pellets
BRPI0413277A (pt) composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
RS53554B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 2-OXO-1-PYROLIDINE DERIVATIVES
DE60022188D1 (de) Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
BRPI0607811A2 (pt) derivados de óxido de pirimidina de 2-(4-cianofenilamino) inibidores de hiv, composição farmacêutica compreendendo os mesmo, processo para preparar a referida composição e uso
BR0307278A (pt) Formulação oral de liberação imediata, e, método para preparar uma formulação
WO2008056375A3 (en) Pharmaceutical formulations comprising valsartan
AR064263A1 (es) Composiciones farmaceuticas que comprenden un compuesto bisfosfato
ATE388695T1 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
UA90700C2 (ru) Оральная композиция немедленного выделения на основе слабоводорастворимого действующего вещества
ATE509620T1 (de) Orale pharmazeutische zusammensetzung einer schwer wasserlöslichen wirksubstanz
BRPI0815531A2 (pt) "compostos, composição farmacêutica, composição cosmética, uso cosmético de uma composição e uso de um composto"
BRPI0516957A (pt) formulação farmacêutica estabilizada de agente de leucotrieno b4 (ltb4)
PE20061050A1 (es) Composicion farmaceutica de liberacion lenta de (+)-(2s,3s)-2-(3-clorofenil)-3,5,5-trimetil-2-morfolinol
AR057853A1 (es) Composicion farmaceutica que logra una excelente absorbencia de la sustancia farmacologicamente activa
SV2006002224A (es) Composicion farmaceutica ref. bhco41368-sv
BRPI0713424A2 (pt) composição farmacêutica oral de um composto ativo fracamente solúvel em água, e, método para sua preparação

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties